Xadago® (safinamide)
for Parkinson’s Disease

Xadago (safinamide) is a monoamine oxidase inhibitor (MAO-B) used with levodopa and carbidopa to treat "wearing-off" episodes in people with Parkinson's disease. It works by increasing the levels of dopamine in the brain, which helps improve movement-related symptoms like muscle stiffness and loss of control. Xadago allows dopamine to work longer, providing symptom relief for Parkinson's disease by enhancing its effects on the brain.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Parkinson’s Disease